Both in Pharmaceuticals
InMed Pharmaceuticals vs Biomea Fusion
Over the past year INM returned +405.8% and BMEA returned −51.4%; their daily moves had a correlation of 0.02.
INM +405.8% BMEA −51.4%Growth of $1, one year, split-adjusted
| Metric | INM | BMEA |
|---|---|---|
| Price | $8.75 | $0.6119 |
| Market cap | $48.1M | $44.4M |
| Today | +420.83% | −1.91% |
| 1 month | +557.9% | −51.0% |
| 6 months | +1104.6% | −61.8% |
| Year to date | +725.5% | −50.7% |
| 1 year | +373.0% | −53.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 24.8× | — |
| Net cash | $2.2M | $34.8M |
| Dividend yield | — | — |
| Volatility (60d) | 338.3% | 122.0% |
| Short % of float | 0.1% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).